| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |